TWEAK and LTß signaling during chronic liver disease

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Dwyer, Benjamin J ^a   Olynyk, John K ^a,b,c,d   Ramm, Grant A ^e,f   Tirnitz Parker, Janina E E ^a,b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

^d MURDOCH UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Cancer; Fibrosis; Hepatic stellate cells; Liver progenitor cells; LT ; NF?B; Regeneration; TWEAK

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR5; FIBROBLAST GROWTH FACTOR INDUCIBLE 14; FRACTALKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LYMPHOTOXIN BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDES AND PROTEINS; PYRUVATE KINASE; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ANTIVIRAL THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CHRONIC LIVER DISEASE; CONFOCAL MICROSCOPY; CYTOTOXICITY; DISEASE COURSE; FIBROGENESIS; HEPATITIS; HUMAN; INFLAMMATION; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER REGENERATION; MICROENVIRONMENT; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84895527231     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00039     Document Type: Short Survey

References (56)

1. Theise ND, Saxena R, Portmann BC, Thung SN, Yee H, Chiriboga L, et al. The canals of hering and hepatic stem cells in humans. Hepatology (1999) 30(6):1425-33. doi:10.1002/hep.510300614.
2. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 39(6):1739-45. doi:10.1002/hep.20130.
3. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet (2011) 43(1):34-41. doi:10.1038/ng.722.
4. Espanol-Suner R, Carpentier R, Van Hul N, Legry V, Achouri Y, Cordi S, et al. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology (2012) 143(6):1564.e-75.e. doi:10.1053/j.gastro.2012.08.024.
5. Viebahn CS, Tirnitz-Parker JE, Olynyk JK, Yeoh GC. Evaluation of the "Cellscreen" system for proliferation studies on liver progenitor cells. Eur J Cell Biol (2006) 85(12):1265-74. doi:10.1016/j.ejcb.2006.08.006.
6. Knight B, Tirnitz-Parker JE, Olynyk JK. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice. Gastroenterology (2008) 135(3):969-79. doi:10.1053/j.gastro.2008.05.077.
7. Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology (2005) 41(4):906-15. doi:10.1002/hep.20645.
8. Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology (2007) 45(1):31-41. doi:10.1002/hep.21466.
9. Jung Y, Witek RP, Syn WK, Choi SS, Omenetti A, Premont R, et al. Signals from dying hepatocytes trigger growth of liver progenitors. Gut (2010) 59(5):655-65. doi:10.1136/gut.2009.204354.
10. Grzelak CA, Martelotto LG, Sigglekow ND, Patkunanathan B, Ajami K, Calabro SR, et al. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. J Hepatol (2014) 60(1):143-51. doi:10.1016/j.jhep.2013.08.012.
11. Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun (2013) 4:2823. doi:10.1038/ncomms3823.
12. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell (2010) 141(1):52-67. doi:10.1016/j.cell.2010.03.015.
13. Ruddell RG, Knight B, Tirnitz-Parker JE, Akhurst B, Summerville L, Subramaniam VN, et al. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Hepatology (2009) 49(1):227-39. doi:10.1002/hep.22597.
14. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol (1999) 154(2):537-41. doi:10.1016/S0002-9440(10)65299-6.
15. Sobaniec-Lotowska ME, Lotowska JM, Lebensztejn DM. Ultrastructure of oval cells in children with chronic hepatitis B, with special emphasis on the stage of liver fibrosis: the first pediatric study. World J Gastroenterol (2007) 13(21):2918-22.
16. Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, et al. Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology (2012) 56(6):2142-53. doi:10.1002/hep.25742.
17. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology (2005) 41(4):809-18. doi:10.1002/hep.20650.
18. Roskams T, De Vos R, Desmet V. 'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology (1996) 28(4):291-9. doi:10.1046/j.1365-2559.1996.d01-438.x.
19. Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 16(4):295-308. doi:10.1016/j.ccr.2009.08.021.
20. Lee ES, Han EM, Kim YS, Shin BK, Kim CH, Kim HK, et al. Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma. Am J Clin Pathol (2005) 124(1):31-6. doi:10.1309/LETTWN3LUF516HR0.
21. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med (2006) 12(4):410-6. doi:10.1038/nm1377.
22. Tirnitz-Parker JE, Viebahn CS, Jakubowski A, Klopcic BR, Olynyk JK, Yeoh GC, et al. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology (2010) 52(1):291-302. doi:10.1002/hep.23663.
23. Bird TG, Lu WY, Boulter L, Gordon-Keylock S, Ridgway RA, Williams MJ, et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A (2013) 110(16):6542-7. doi:10.1073/pnas.1302168110.
24. Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med (2012) 18(4):572-9. doi:10.1038/nm.2667.
25. Ramm GA, Shepherd RW, Hoskins AC, Greco SA, Ney AD, Pereira TN, et al. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology (2009) 49(2):533-44. doi:10.1002/hep.22637.
26. Boulter L, Lu WY, Forbes SJ. Differentiation of progenitors in the liver: a matter of local choice. J Clin Invest (2013) 123(5):1867-73. doi:10.1172/JCI66026.
27. Tirnitz-Parker JE, Olynyk JK, Ramm GA. Role of TWEAK in co-regulating liver progenitor cell and fibrogenic responses. Hepatology (2013). doi:10.1002/hep.26701.
28. Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 272(51):32401-10. doi:10.1074/jbc.272.51.32401.
29. Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, et al. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity (2001) 15(5):837-46. doi:10.1016/S1074-7613(01)00232-1.
30. Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, et al. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol (2000) 156(4):1253-61. doi:10.1016/S0002-9440(10)64996-6.
31. Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine (2007) 40(1):1-16. doi:10.1016/j.cyto.2007.09.007.
32. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest (2005) 115(9):2330-40. doi:10.1172/JCI23486.
33. Viebahn CS, Benseler V, Holz LE, Elsegood CL, Vo M, Bertolino P, et al. Invading macrophages play a major role in the liver progenitor cell response to chronic liver injury. J Hepatol (2010) 53(3):500-7. doi:10.1016/j.jhep.2010.04.010.
34. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell (2008) 132(3):344-62. doi:10.1016/j.cell.2008.01.020.
35. Shih VF, Tsui R, Caldwell A, Hoffmann A. A single NFkappaB system for both canonical and non-canonical signaling. Cell Res (2011) 21(1):86-102. doi:10.1038/cr.2010.161.
36. Elsharkawy AM, Mann DA. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology (2007) 46(2):590-7. doi:10.1002/hep.21802.
37. Gao R, Brigstock DR. Activation of nuclear factor kappa B (NF-kappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells. Cell Commun Signal (2005) 3:14. doi:10.1186/1478-811X-3-14.
38. Hellerbrand C, Jobin C, Iimuro Y, Licato L, Sartor RB, Brenner DA. Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology (1998) 27(5):1285-95. doi:10.1002/hep.510270514.
39. Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ (1999) 10(12):819-28.
40. Subrata LS, Lowes KN, Olynyk JK, Yeoh GC, Quail EA, Abraham LJ. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines. Liver Int (2005) 25(3):633-46. doi:10.1111/j.1478-3231.2005.01080.x.
41. Subrata LS, Voon DC, Yeoh GC, Ulgiati D, Quail EA, Abraham LJ. TNF-inducible expression of lymphotoxin-beta in hepatic cells: an essential role for NF-kappaB and Ets1 transcription factors. Cytokine (2012) 60(2):498-504. doi:10.1016/j.cyto.2012.05.029.
42. Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N, Yamaoka S. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem (2003) 278(38):36005-12. doi:10.1074/jbc.M304266200.
43. Brown SA, Richards CM, Hanscom HN, Feng SL, Winkles JA. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem J (2003) 371(Pt 2):395-403. doi:10.1042/BJ20021730.
44. Kuramitsu K, Sverdlov DY, Liu SB, Csizmadia E, Burkly L, Schuppan D, et al. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol (2013) 183(1):182-94. doi:10.1016/j.ajpath.2013.03.018.
45. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest (2005) 115(1):56-65. doi:10.1172/JCI22675.
46. Ware CF, Vanarsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol (1995) 198:175-218.
47. Lee CM, Knight B, Yeoh GC, Ramm GA, Olynyk JK. Lymphotoxin-beta production following bile duct ligation: possible role for Kupffer cells. J Gastroenterol Hepatol (2005) 20(11):1762-8. doi:10.1111/j.1440-1746.2005.04065.x.
48. Akhurst B, Matthews V, Husk K, Smyth MJ, Abraham LJ, Yeoh GC. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury. Hepatology (2005) 41(2):327-35. doi:10.1002/hep.20520.
49. Knight B, Matthews VB, Akhurst B, Croager EJ, Klinken E, Abraham LJ, et al. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol Cell Biol (2005) 83(4):364-74. doi:10.1111/j.1440-1711.2005.01346.x.
50. Lowes KN, Croager EJ, Abraham LJ, Olynyk JK, Yeoh GC. Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut (2003) 52(9):1327-32. doi:10.1136/gut.52.9.1327.
51. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J Immunol (1992) 149(12):3881-8.
52. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 3(11):e442. doi:10.1371/journal.pmed.0030442.
53. Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology (2005) 42(5):1208-36. doi:10.1002/hep.20933.
54. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 359(4):378-90. doi:10.1056/NEJMoa0708857.
55. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 25(2):181-200. doi:10.1055/s-2005-871198.
56. Lim R, Knight B, Patel K, Mchutchison JG, Yeoh GC, Olynyk JK. Antiproliferative effects of interferon alpha on hepatic progenitor cells in vitro and in vivo. Hepatology (2006) 43(5):1074-83. doi:10.1002/hep.21170.